News headlines about Quidel Corporation (NASDAQ:QDEL) have been trending somewhat positive on Friday, according to Accern Sentiment. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Quidel Corporation earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.6048728124496 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of Quidel Corporation (NASDAQ QDEL) traded up 2.45% during mid-day trading on Friday, reaching $33.40. The company’s stock had a trading volume of 314,044 shares. The firm’s market cap is $1.12 billion. The firm’s 50 day moving average is $31.16 and its 200 day moving average is $24.85. Quidel Corporation has a one year low of $18.25 and a one year high of $38.92.
Quidel Corporation (NASDAQ:QDEL) last posted its earnings results on Wednesday, July 26th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.18. Quidel Corporation had a negative return on equity of 0.03% and a negative net margin of 0.03%. The firm had revenue of $38.30 million for the quarter, compared to analysts’ expectations of $41.91 million. During the same period in the previous year, the company earned ($0.11) earnings per share. The company’s revenue was down 2.0% compared to the same quarter last year. On average, equities analysts anticipate that Quidel Corporation will post $0.28 earnings per share for the current fiscal year.
A number of research analysts have commented on QDEL shares. Zacks Investment Research lowered Quidel Corporation from a “hold” rating to a “strong sell” rating in a research report on Saturday, July 29th. BidaskClub lowered Quidel Corporation from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 16th. TheStreet lowered Quidel Corporation from a “b-” rating to a “c” rating in a research report on Wednesday, July 26th. William Blair raised Quidel Corporation from a “market perform” rating to an “outperform” rating in a research report on Tuesday, July 18th. Finally, Barclays PLC raised their price objective on Quidel Corporation from $26.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, April 26th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $31.40.
ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/08/11/quidel-corporation-nasdaqqdel-earning-somewhat-favorable-news-coverage-study-finds-updated.html.
In related news, CEO Douglas C. Bryant sold 36,000 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $33.83, for a total transaction of $1,217,880.00. Following the completion of the transaction, the chief executive officer now owns 296,493 shares in the company, valued at approximately $10,030,358.19. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Michael Donald Jr. Abney sold 1,173 shares of the stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $33.83, for a total transaction of $39,682.59. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 227,388 shares of company stock valued at $6,951,432. Insiders own 22.00% of the company’s stock.
About Quidel Corporation
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
What are top analysts saying about Quidel Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Quidel Corporation and related companies.